These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20878402)

  • 61. Comparison of the Diagnostic Performances of Ultrasound, High-Resolution Magnetic Resonance Imaging, and Positron Emission Tomography/Computed Tomography in a Rabbit Carotid Vulnerable Plaque Atherosclerosis Model.
    Xu L; Wang R; Liu H; Wang J; Liang W; Mang J; Xu Z
    J Ultrasound Med; 2020 Nov; 39(11):2201-2209. PubMed ID: 32395879
    [TBL] [Abstract][Full Text] [Related]  

  • 62. (18)F-FDG in distinction of atherosclerotic plaque: Innovation in PET/MRI technology.
    Benedetto R; Carneiro MP; Junqueira FA; Coutinho A; von Ristow A; Fonseca LM
    Arq Bras Cardiol; 2009 Dec; 93(6):e84-7, e97-100. PubMed ID: 20379625
    [No Abstract]   [Full Text] [Related]  

  • 63. Molecular imaging of atherosclerosis: a progress report.
    Libby P; Nahrendorf M; Weissleder R
    Tex Heart Inst J; 2010; 37(3):324-7. PubMed ID: 20548813
    [No Abstract]   [Full Text] [Related]  

  • 64. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
    Zhao ZM; Qin SC
    Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Radiological diagnostics and follow-up of rectal carcinoma].
    Vogl TJ; Pegios W; Bechstein WO; Floeter J
    Rofo; 2006 Oct; 178(10):970-8. PubMed ID: 17021976
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CT and MRI in monitoring response: state-of-the-art and future developments.
    D'Ippolito G; Torres LR; Saito Filho CF; Ferreira RM
    Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):603-19. PubMed ID: 22231581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular imaging of vascular inflammation.
    Tahara N; Tahara A; Honda A; Nitta Y; Kodama N; Yamagishi S; Imaizumi T
    Curr Pharm Des; 2014; 20(14):2439-47. PubMed ID: 23844819
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Advances in PET: The success of multimodal molecular imaging.
    Martínez-Rodríguez I; Banzo I
    Med Clin (Barc); 2017 Apr; 148(8):354-356. PubMed ID: 28038850
    [No Abstract]   [Full Text] [Related]  

  • 70. Developments of magnetic resonance imaging and spectroscopy in the field of molecular imaging.
    Aime S; Bisi G
    Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):563-4. PubMed ID: 20016449
    [No Abstract]   [Full Text] [Related]  

  • 71. Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?
    Alavi A; Basu S
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1554-9. PubMed ID: 18594816
    [No Abstract]   [Full Text] [Related]  

  • 72. The clinical application of PET/CT: a contemporary review.
    Brady Z; Taylor ML; Haynes M; Whitaker M; Mullen A; Clews L; Partridge M; Hicks RJ; Trapp JV
    Australas Phys Eng Sci Med; 2008 Jun; 31(2):90-109. PubMed ID: 18697701
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The rise and fall of PET and PET/CT: a German perspective.
    Mohnike W
    Nuklearmedizin; 2005; 44 Suppl 1():S58-60. PubMed ID: 16395981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. PET-CT--comments on the white paper.
    Biersack HJ
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1576. PubMed ID: 18566817
    [No Abstract]   [Full Text] [Related]  

  • 75. Advances in multimodality imaging through a hybrid PET/MRI system.
    Fatemi-Ardekani A; Samavati N; Tang J; Kamath MV
    Crit Rev Biomed Eng; 2009; 37(6):495-515. PubMed ID: 20565381
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Has the development of PET come to an end with PET-CT?].
    Bockisch A; Rosenbaum S
    Rofo; 2005 Jan; 177(1):14-6. PubMed ID: 15657815
    [No Abstract]   [Full Text] [Related]  

  • 77. The PET/CT report: the most important part of the study.
    Graham MM
    J Nucl Med; 2010 Jan; 51(1):5-6. PubMed ID: 20008996
    [No Abstract]   [Full Text] [Related]  

  • 78. 18F-DOPA PET and PET/CT.
    Nanni C; Fanti S; Rubello D
    J Nucl Med; 2007 Oct; 48(10):1577-9. PubMed ID: 17909255
    [No Abstract]   [Full Text] [Related]  

  • 79. [Positron emission tomography/magnetic resonance: Present and future].
    Kohan AA; Vercher Conejero JL; Gaeta MC; Pelegrí Martinez L; Ros PR
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):167-76. PubMed ID: 23582491
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.